TY  - JOUR

T1  - Navelbine® (NVB) alternating oral and i.v. plus epirubicin (EPI) as first line chemotherapy of metastatic breast cancer (MBC): phase II study — final results

JO  - European Journal of Cancer Supplements

PY  - 2004/03/01

AU  - Serin D

AU  - Verrill M

AU  - Jones A

AU  - Delozier T

AU  - Coleman R

AU  - Longerey B

AU  - Lafaye de Micheaux S

ED  - 

DO  - DOI: 10.1016/s1359-6349(04)90860-9

PB  - Elsevier BV

VL  - 2

IS  - 3

SP  - 130

EP  - 131

Y2  - 2025/10/10

ER  -